Principal Financial Group Inc. Raises Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT)

Principal Financial Group Inc. increased its stake in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) by 3.0% during the first quarter, according to its most recent filing with the SEC. The institutional investor owned 111,865 shares of the medical instruments supplier’s stock after purchasing an additional 3,248 shares during the period. Principal Financial Group Inc. owned 0.50% of LeMaitre Vascular worth $9,385,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in LMAT. Opal Wealth Advisors LLC purchased a new stake in shares of LeMaitre Vascular in the 1st quarter valued at about $26,000. NBC Securities Inc. purchased a new stake in shares of LeMaitre Vascular in the 1st quarter valued at about $36,000. Huntington National Bank raised its holdings in shares of LeMaitre Vascular by 64.9% in the 4th quarter. Huntington National Bank now owns 1,156 shares of the medical instruments supplier’s stock valued at $107,000 after acquiring an additional 455 shares in the last quarter. Canada Pension Plan Investment Board raised its holdings in shares of LeMaitre Vascular by 112.5% in the 4th quarter. Canada Pension Plan Investment Board now owns 1,700 shares of the medical instruments supplier’s stock valued at $157,000 after acquiring an additional 900 shares in the last quarter. Finally, Summit Investment Advisors Inc. raised its holdings in shares of LeMaitre Vascular by 8.2% in the 4th quarter. Summit Investment Advisors Inc. now owns 2,122 shares of the medical instruments supplier’s stock valued at $196,000 after acquiring an additional 160 shares in the last quarter. Hedge funds and other institutional investors own 84.64% of the company’s stock.

LeMaitre Vascular Stock Performance

NASDAQ:LMAT opened at $84.09 on Tuesday. The business’s 50-day moving average price is $82.72 and its two-hundred day moving average price is $88.07. LeMaitre Vascular, Inc. has a twelve month low of $71.42 and a twelve month high of $109.58. The stock has a market cap of $1.90 billion, a P/E ratio of 42.47, a PEG ratio of 2.21 and a beta of 0.82. The company has a quick ratio of 13.83, a current ratio of 16.49 and a debt-to-equity ratio of 0.48.

LeMaitre Vascular (NASDAQ:LMAT) last released its quarterly earnings results on Thursday, May 1st. The medical instruments supplier reported $0.48 earnings per share for the quarter, missing the consensus estimate of $0.50 by ($0.02). The business had revenue of $59.87 million during the quarter, compared to analysts’ expectations of $57.61 million. LeMaitre Vascular had a net margin of 19.96% and a return on equity of 13.53%. The business’s revenue was up 12.0% on a year-over-year basis. During the same period in the previous year, the business earned $0.44 EPS. As a group, equities analysts predict that LeMaitre Vascular, Inc. will post 1.94 EPS for the current fiscal year.

LeMaitre Vascular Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, May 29th. Investors of record on Thursday, May 15th were issued a dividend of $0.20 per share. The ex-dividend date of this dividend was Thursday, May 15th. This represents a $0.80 dividend on an annualized basis and a dividend yield of 0.95%. LeMaitre Vascular’s dividend payout ratio is 40.40%.

Insider Buying and Selling at LeMaitre Vascular

In related news, CEO George W. Lemaitre sold 76,868 shares of the firm’s stock in a transaction dated Monday, May 19th. The stock was sold at an average price of $85.79, for a total transaction of $6,594,505.72. Following the transaction, the chief executive officer directly owned 1,796,783 shares of the company’s stock, valued at approximately $154,146,013.57. This trade represents a 4.10% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Over the last 90 days, insiders sold 100,000 shares of company stock worth $8,556,857. Company insiders own 9.50% of the company’s stock.

About LeMaitre Vascular

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.